Actor
Novigenix SA
Precision medicine biotech providing a new understanding of the human host response to cancer therapy. Novigenix’s unique Immuno-Transcriptomic platform enables an accelerated identification of disease specific mRNA signatures of immune cells, which combined with machine learning and predictive algorithms provide new insights into onset and progression of disease.
Specialties
Primary Therapeutic Areas
1.5 Medical Technology
1.52 Diagnostic & In-Vitro Device
3.1 e-Health
3.11 Medical data center & recording
3.2 Health IT
3.20 Big data & IoT
3.4 Personalized Medicine
3.41 Monitoring
Business model
1. Entreprise
1.2 Scale-Up
Organization Type
Private Company
Visit website
Domains
Immunology & Allergy, Oncology
Main sector
Medtech
Contact
Biopôle IV, Route de la Corniche 3B
1066 Epalinges / VD
021 552 07 30